This positive recommendation follows a regularly scheduled meeting of the data safety monitoring board (DSMB) in June 2008, and is based upon an evaluation of clinical, magnetic resonance
The Phase III study will involve up to 750 patients with Type-1 Diabetes Mellitus centers in the US, Canada, Russia, and Eastern Europe. Dosing of patients is now
As part of this 10 year agreement (with two additional five year renewal terms), Luitpold will continue to contract manufacture these products for Fresenius Medical Care. The transaction
Loxonin tape is said to be the first loxoprofen sodium adhesive tape in Japan containing the same constituents as Loxonin pills and Loxonin powder which are the leading
The ongoing pregnancy rate, the primary endpoint of this non-inferiority trial, obtained in the 150mcg corifollitropin alfa treatment arm (38.9% per started cycle) was similar to that achieved
Angiotech will contribute to Angiotech Pharmaceutical Interventions (API) certain business assets and intellectual property, which include primarily business assets of Angiotech other than the intellectual property and royalty
The companies plan to design, develop and manufacture solutions, which include sensors and delivery products, to support targeted markets enabling the advancement of patient care. These products will
Patheon will provide formulation and analytical development services as well as clinical supplies for one of the CNS candidates in multiple dosage forms for SK Life Science’s advanced
The studies performed at US based CRO are expected to produce results allowing Akela to start the longer term safety arm of the Fentanyl Taifun Phase III clinical
The study treatments include clevudine 30mg/day, tenofovir 300mg/day or the combination of both drugs administered to 150 treatment-naive hepatitis B e-antigen negative hepatitis B virus (HBV)-infected patients for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.